¼¼°èÀÇ ºÒ¸éÁõ Ä¡·á ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ÆÇ¸Å ä³Îº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2025-2030³â)
Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1678714
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ºÒ¸éÁõ Ä¡·á ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ºÒ¸éÁõ Ä¡·á ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 37¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2030³â±îÁö CAGR 4.5%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÁַΠƯÇã¹ÞÀº ºÐÀÚÀÇ Á¸Àç, ÀáÀçÀûÀÎ ÀÓ»ó ÆÄÀÌÇÁ¶óÀÎ Èĺ¸, ½ºÆ®·¹½º ¼öÁØÀÇ »ó½Â, ¼ö¸éÀÌ ¾î·Á¿î ³ëÀÎ Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ºÒ¸éÁõÀÇ À¯º´·ü Áõ°¡, ÀÌ Áúº´¿¡ ´ëÇÑ ÀνÄ, º¸´Ù ¾ÈÀüÇÑ ¾à¹°ÀÇ °¡¿ë¼º µîÀÌ ¼öÀÍ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÒ¸éÁõÀº ¼¼°è Àα¸ÀÇ ¾à 35%°¡ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ºÒ¸éÁõÀÇ ´Ù¾çÇÑ ÆÐÅÏ¿¡´Â ¼ö¸é ¹× ¼ö¸é À¯Áö Àå¾Ö°¡ ÀÖÀ¸¸ç, ÀϹÝÀûÀ¸·Î ºó¹øÇÑ °¢¼º°ú ³Ê¹« ºü¸¥ °¢¼ºÀ» µ¿¹ÝÇÏ°í ´Ù½Ã ÀáÀ» ÀڱⰡ ¾î·Æ½À´Ï´Ù. Àå±â°£ÀÇ ºÒ¸éÁõÀº ÀÏ»ó»ýȰ¿¡ ÁöÀåÀ» ÃÊ·¡ÇÏ¿©, ±× °á°ú ºñ»ý»êÀûÀÎ ³ëµ¿½Ã°£ÀÌ µÉ ¼öµµ ÀÖ½À´Ï´Ù. ÀÌ »óŸ¦ ¹æÄ¡ÇÏ¸é ½ÉÇÑ ¿ì¿ïÁõ°ú ½Å°æ ¼è¾àÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

ºÒ¸éÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎÀ¸·Î´Â ½ºÆ®·¹½º ¼öÁØ »ó½Â, ½ÃÀå¿¡¼­ ƯÇã ºÐÀÚÀÇ Á¸Àç, ÀÓ»ó ÆÄÀÌÇÁ¶óÀο¡ ÀÖ´Â ÀáÀçÀûÀÎ ¾à¹°, ÷´Ü ±â¼ú ÀÇ·á±â±âÀÇ µµÀÔ, ³ëÀÎ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¼ö¸éºÎÁ·ÀÌ ÀÏ»ó»ýȰ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â ºÒ¸éÁõ¿¡ ´ëÇÑ ´Ù¾çÇÑ Ä¡·á¹ýÀÇ Ã¤¿ë·üÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç ºÒ¸éÁõ Ä¡·á ½ÃÀåÀÇ ¼öÀÍ ¼ºÀåÀ¸·Î À̾îÁú °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

ÇöÀç ºÒ¸éÁõÀÇ Ä¡·á·Î¼­ ³Î¸® ä¿ëµÇ°í ÀÖ´Â °ÍÀº ¿À·º½Å ±æÇ×Á¦³ª ¸á¶óÅä´Ñ ±æÇ×Á¦ µîÀÇ ½Å±Ô ¾àÁ¦°¡ ½ÃÀå¿¡ ³ª¿Í ÀÖ´Â Á¦³×¸¯ ºñº¥Á¶µð¾ÆÁ¦ÇÉ°è ¾àÁ¦³ª Ç׿ì¿ïÁ¦ µîÀÔ´Ï´Ù. EisaiÀÇ Lemborexant ¹ß¸Å´Â ÀÌ ºÎ¹®¿¡ À־ÀÇ ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä¿¡ ÀÀÇØ, ¿¹Ãø ±â°£Áß ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. 2015³â À¯¿£ º¸°í¼­¿¡ µû¸£¸é 60¼¼ ÀÌ»óÀÇ Àα¸´Â 56% Áõ°¡ÇßÀ¸¸ç 2030³â¿¡´Â ¾à 14¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Åë°è´Â ³ëÀÎÀÌ Áõ°¡Çϰí ÀÖÀ½À» ³ªÅ¸³À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ÃþÀº ¼ö¸é ºÎÁ·¿¡ ºüÁö±â ½±±â ¶§¹®¿¡ ºÒ¸éÁõ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÒ¸éÁõ Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ºÒ¸éÁõ Ä¡·á ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ºÒ¸éÁõ Ä¡·á ½ÃÀå : À¯Çü ºñÁî´Ï½º ºÐ¼®

Á¦5Àå ºÒ¸éÁõ Ä¡·á ½ÃÀå : ÆÇ¸Å ä³Î ºñÁî´Ï½º ºÐ¼®

Á¦6Àå ºÒ¸éÁõ Ä¡·á ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Insomnia Therapeutics Market Growth & Trends:

The global insomnia therapeutics market size is expected to reach USD 3.74 billion by 2030, registering a CAGR of 4.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai's Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Insomnia Therapeutics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Insomnia Therapeutics Market Variables, Trends, & Scope

Chapter 4. Insomnia Therapeutics Market: Type Business Analysis

Chapter 5. Insomnia Therapeutics Market: Sales Channel Business Analysis

Chapter 6. Insomnia Therapeutics Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â